ABC | Volume 113, Nº3, September 2019

Original Article Dracoulakis et al. High platelet activity during ASA use in ACS Arq Bras Cardiol. 2019; 113(3):357-363 This is an open-access article distributed under the terms of the Creative Commons Attribution License 27. Mehta SR, Tanguay JF, Eikelboom JW, Jolly SS, Joyner CD, Granger CB, et al. Double-dose versus standard-dose clopidogrel and high-dose versus low- dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. Lancet. 2010; 376(9748):1233-43. 28. BernlochnerI,SteinhublS,BraunS,MorathT,JaitnerJ,StegherrJ,etal.Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment. ThrombHaemost. 2010;104(6):1193-200. 29. Tantry US, Bliden KP, Suarez TA, Kreutz RP, Dichiara J, Gurbel PA. Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: Results of the Thrombotic Risk Progression (TRIP) Study. Platelets. 2010;21(5):360-7. 30. Ziegler S, Alt E, Brunner M, Speiser W, Minar E. Influence of systemic inflammation on the interpretation of response to antiplatelet therapy, monitored by PFA-100. Semin Thromb Hemost. 2005;31(4):416-9. 363